|
|
Vaccine Detail
|
Tripedia |
| Vaccine Information |
- Vaccine Name: Tripedia
- Target Pathogen: Bordetella pertussis
- Target Disease: Whooping Cough
- Product Name: Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed
- Tradename: Tripedia
- Manufacturer: Sanofi Pasteur, Inc.
- Vaccine Ontology ID: VO_0000112
- CDC CVX code: 20
- Type: Toxoid vaccine
- Status: Licensed
- Location Licensed: USA (FDA License #1725)
- Host Species for Licensed Use: Human
- Adjuvant:
- Adjuvant name:
- VO adjuvant ID: VO_0000193
- Description: Tripedia vaccine combines diptheria and tetanus toxoids with purified pertussis antigens. It consists of 3 doses administered at intervals of 4-8 weeks (FDA: Tripedia).
- Immunization Route: Intramuscular injection (i.m.)
- Storage: Store between 2 and 8 degrees Celsius. DO NOT FREEZE.
- Approved Age for Licensed Use: Tripedia vaccine is indicated for active immunization against diphtheria, tetanus, and pertussis simultaneously in infants and children 6 weeks to 7 years of age (prior to seventh birthday). Due to substantial risks of complications of the disease, completion of a primary series of pertussis vaccine early in life is strongly recommended (FDA: Tripedia).
- Contraindication: This vaccine should not be administered to anyone with a known hypersensitivity to any component of the vaccine.
- Description: Tripedia vaccine combines diptheria and tetanus toxoids with purified pertussis antigens. It consists of 3 doses administered at intervals of 4-8 weeks (FDA: Tripedia).
|
| Host Response |
|
|
| References |
FDA: Tripedia: FDA: Tripedia [http://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm101565.htm]
|
|
